TargetMol

TG-46

Product Code:
 
TAR-T20743
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T20743-1mg1mg£227.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T20743-5mg5mg£416.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T20743-10mg10mg£593.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T20743-25mg25mg£962.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T20743-50mg50mg£1,420.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T20743-100mg100mg£2,111.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
TG-46 is an inhibitor of JAK2, JAK3, FLT3, and RET.
CAS:
936091-15-5
Formula:
C26H34N6O3S
Molecular Weight:
510.66
Pathway:
Chromatin/Epigenetic|Angiogenesis|Stem Cells|Tyrosine Kinase/Adaptors|JAK/STAT signaling
Purity:
0.98
SMILES:
Cc1cnc(Nc2ccc(CN3CCOCC3)cc2)nc1Nc1cccc(c1)S(=O)(=O)NC(C)(C)C
Target:
FLT|JAK

References

1. Kim EY, Lee JW, Lee MY, Kim SH, Mok HJ, Ha K, Ahn YM, Kim KP. Serum lipidomic analysis for the discovery of biomarkers for major depressive disorder in drug-free patients. Psychiatry Res. 2018 Jul;265:174-182. doi: 10.1016/j.psychres.2018.04.029. Epub 2018 Apr 25. PubMed PMID: 29719272. 2. Belkoff L, Brock G, Carrara D, Neijber A, Ando M, Mitchel J. Efficacy and safety of testosterone replacement gel for treating hypogonadism in men: Phase III open-label studies. Andrologia. 2018 Feb;50(1). doi: 10.1111/and.12801. Epub 2017 Mar 10. PubMed PMID: 28295450. 3. Al Faris NA, Al Othman ZA, Ahmad D. Effects of Mesembrrybryanthemum forsskalei Hochst seeds in lowering glucose/lipid profile in streptozotocin-induced diabetic rats. J Food Sci Technol. 2011 Oct;48(5):616-21. doi: 10.1007/s13197-010-0152-8. Epub 2010 Nov 5. PubMed PMID: 23572796; PubMed Central PMCID: PMC3551122. 4. Quraishi SA, Schuler GH, Janicki PK. 5 HT(3)-receptor antagonists and cardiac repolarization time in patients expressing a novel genetic target associated with baseline QTc interval abnormalities. J Clin Anesth. 2011 Jun;23(4):297-302. doi: 10.1016/j.jclinane.2010.11.003. PubMed PMID: 21663814.